Advances in understanding the pathogenesis of HLH
- 12 April 2013
- journal article
- review article
- Published by Wiley in British Journal of Haematology
- Vol. 161 (5), 609-622
- https://doi.org/10.1111/bjh.12293
Abstract
Haemophagocytic lymphohistiocytosis (HLH) is a hyperinflammatory disorder resulting from immune dysfunction reflecting either primary immune deficiency or acquired failure of normal immune homeostasis. Familial HLH includes autosomal recessive and X-linked disorders characterized by uncontrolled activation of T cells and macrophages and overproduction of inflammatory cytokines, secondary to defects in genes encoding proteins involved in granule-dependent cytolytic pathways. In older children and adults, HLH is associated more often with infections, malignancies, autoimmune diseases, and acquired immune deficiencies. HLH, macrophage activation syndrome, sepsis, and systemic inflammatory response syndrome are different clinical entities that probably represent a common immunopathological state, termed cytokine storm. These conditions may be clinically indistinguishable; all include massive inflammatory response, elevated serum cytokine levels, multi-organ involvement, haemophagocytic macrophages, and often death. Tissues of haematopoietic and lymphoid function are directly involved; other organs are secondarily damaged by circulating cytokines and chemokines. Haemophagocytic disorders are now increasingly diagnosed in the context of severe inflammatory reactions to viruses, malignancies and systemic connective tissue diseases. Many of these cases may reflect underlying genetic predispositions to HLH. The detection of gene defects has contributed considerably to our understanding of HLH, but the mechanisms leading to acquired HLH have yet to be fully determinedThis publication has 101 references indexed in Scilit:
- Hemophagocytic lymphohistiocytosis with MUNC13‐4 gene mutation or reduced natural killer cell function prior to onset of childhood leukemiaPediatric Blood & Cancer, 2010
- Munc18-2 deficiency causes familial hemophagocytic lymphohistiocytosis type 5 and impairs cytotoxic granule exocytosis in patient NK cellsJCI Insight, 2009
- Familial Hemophagocytic Lymphohistiocytosis Type 5 (FHL-5) Is Caused by Mutations in Munc18-2 and Impaired Binding to Syntaxin 11American Journal of Human Genetics, 2009
- Temperature sensitivity of human perforin mutants unmasks subtotal loss of cytotoxicity, delayed FHL, and a predisposition to cancerProceedings of the National Academy of Sciences of the United States of America, 2009
- Association of Monoclonal Expansion of Epstein-Barr Virus-Negative CD158a + NK Cells Secreting Large Amounts of Gamma Interferon with Hemophagocytic LymphohistiocytosisClinical and Vaccine Immunology, 2009
- Macrophage activation syndrome in patients with systemic juvenile idiopathic arthritis is associated with MUNC13‐4 polymorphismsArthritis & Rheumatism, 2008
- Cytophagic histiocytic panniculitis with fatal haemophagocytic lymphohistiocytosis in a paediatric patient with perforin gene mutationJournal of Clinical Pathology, 2007
- Novel Munc13-4 mutations in children and young adult patients with haemophagocytic lymphohistiocytosisJournal of Medical Genetics, 2006
- Perforin polymorphism A91V and susceptibility to B-precursor childhood acute lymphoblastic leukemia: a report from the Children's Oncology GroupLeukemia, 2006
- Spectrum and clinical implications of syntaxin 11 gene mutations in familial haemophagocytic lymphohistiocytosis: association with disease-free remissions and haematopoietic malignanciesJournal of Medical Genetics, 2005